Healthcare -
Biotechnology - NASDAQ - US
$ 1.81
2.84 %
$ 1.15 B
Market Cap
-6.7
P/E
Price Target
Average
231.49%
Revenue Forecast
Estimate
1596.52%
EBIT
Estimate
--81.38%
Net Income
Estimate
65.62%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Geron Corporation
Wall Street analysts predict an average 1-year price target for GERN of $6 , with forecasts ranging from
a
low of
$4.5 to a high of $8 .
GERN Lowest Price Target
Wall Street Target
4.5 USD
148.62%
GERN Average Price Target
Wall Street Target
6 USD
231.49%
GERN Highest Price Target
Wall Street Target
8 USD
341.99%
REVENUE FORECAST
Revenue Forecast Chart GERN
EBIT FORECAST
EBIT Forecast Chart GERN
NET INCOME FORECAST
Net Income Chart GERN